Copyright
©The Author(s) 2025.
World J Stem Cells. Oct 26, 2025; 17(10): 110058
Published online Oct 26, 2025. doi: 10.4252/wjsc.v17.i10.110058
Published online Oct 26, 2025. doi: 10.4252/wjsc.v17.i10.110058
Figure 1 Summary of mesenchymal stem cells-derived microRNAs, their targets, and signaling pathways involved in ocular diseases.
AKT: Protein kinase B; HIF: Hypoxia-inducible factor; HIPK2: Homeodomain-interacting protein kinase 2; HOXC6: Homeobox C6; IL: Interleukin; IRAK1: Interleukin 1-receptor associated kinase 1; MAPK: Mitogen-activated protein kinase; mTOR: Mechanistic target of rapamycin; NF-кB: Nuclear factor kappa B; PI3K: Phosphatidylinositol 3-kinase; PLCG1: Phospholipase C gamma 1; PTEN: Phosphatase and tensin homolog; STAT3: Signal transducer and activator of transcription 3; TGF: Transforming growth factor; TLR4: Toll-like receptor 4.
- Citation: Nair S, Chidambaranathan GP. Mesenchymal stem cell-derived microRNAs: Key immunomodulators to prevent ocular tissue degeneration. World J Stem Cells 2025; 17(10): 110058
- URL: https://www.wjgnet.com/1948-0210/full/v17/i10/110058.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i10.110058
